National Institute of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting, 15691 [2021-06020]
Download as PDF
<![CDATA[
15691
Federal Register / Vol. 86, No. 55 / Wednesday, March 24, 2021 / Notices
TABLE 1—LIST OF SAFETY AND EFFECTIVENESS SUMMARIES FOR APPROVED PMAS AND SAFETY AND PROBABLE BENEFIT
SUMMARIES FOR APPROVED HDES MADE AVAILABLE FROM OCTOBER 1, 2018, THROUGH DECEMBER 31, 2020—
Continued
PMA No., Docket No.
Applicant
Trade name
H190001, FDA–2020–M–2248
P190030, FDA–2020–M–2288
P200030, FDA–2020–M–2339
HDL Therapeutics, Inc ...........
Theragen, Inc .........................
W. L. Gore and Associates,
Inc.
Plasma Delipidation System (PDS–2TM System) ...................
ActaStim-S Spine Fusion Stimulator .......................................
GORE® EXCLUDER® Conformable AAA Endoprosthesis
(EXCC).
II. Electronic Access
Persons with access to the internet
may obtain the documents at https://
www.fda.gov/MedicalDevices/
ProductsandMedicalProcedures/Device
ApprovalsandClearances/
PMAApprovals/default.htm.
Dated: March 15, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for
Policy.
[FR Doc. 2021–06052 Filed 3–23–21; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the NIH Clinical Center
Research Hospital Board.
The meeting will be held as a virtual
meeting and open to the public.
Individuals who plan to view the virtual
meeting and need special assistance or
other reasonable accommodations to
view the meeting should notify the
Contact Person listed below in advance
of the meeting. The meeting can be
accessed from the NIH Videocast
https://videocast.nih.gov/ and the
CCRHB website https://
ccrhb.od.nih.gov/meetings.html.
Name of Committee: NIH Clinical Center
Research Hospital Board.
Date: April 23, 2021.
Time: 9:00 a.m. to 1:00 p.m.
Agenda: Clinical Center CEO Update,
Patient Safety and Clinical Quality Update,
other business of the Board.
Place: National Institutes of Health,
Building 1, 9000 Rockville Pike, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Gretchen Wood, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892,
301–496–4272, woodgs@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
VerDate Sep<11>2014
16:30 Mar 23, 2021
Jkt 253001
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: March 18, 2021.
Patricia B. Hansberger,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2021–06021 Filed 3–23–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and
Digestive and Kidney Diseases;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Diabetes and
Digestive and Kidney Diseases Advisory
Council, May 12, 2021, 10:00 a.m. to
May 13, 2021, 01:45 p.m., National
Institutes of Health, Two Democracy
Plaza, 6707 Democracy Boulevard,
Bethesda, MD, 20892 which was
published in the Federal Register on
December 28, 2020, 85 FR 84358.
This notice is being amended to
change the meeting time from 10:00
a.m.–1:15 p.m. on May 12, 2021 to 10:00
a.m.–3:00 p.m. on May 12, 2021. The
meeting is to the public.
Dated: March 18, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–06020 Filed 3–23–21; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Approval date
12/1/2020
12/9/20
12/22/20
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
Docket ID: FEMA–2020–0036; OMB No.
1660–0105]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request; National
Household Survey on Disaster
Preparedness
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: 30-Day notice of revision and
request for comments.
AGENCY:
The Federal Emergency
Management Agency (FEMA), as part of
its continuing effort to reduce
paperwork and respondent burden,
invites the general public to take this
opportunity to comment on a revision of
a currently approved information
collection. In accordance with the
Paperwork Reduction Act of 1995, this
notice seeks comments concerning the
charge to FEMA and the Department of
Homeland Security (DHS) to meet
FEMA strategic priorities, and FEMA’s
program management to improve the
public’s knowledge and actions for
preparedness and resilience.
Information from this collection will be
used to track changes in knowledge,
attitudes, and behaviors related to
preparedness in the general public. The
Individual and Community
Preparedness Division analyzes and
uses data collected in FEMA Form 008–
0–15, National Disaster Preparedness
Survey to identify progress and gaps in
individual and community
preparedness to better understand the
motivators and barriers to preparedness
in general and about specific hazards.
The survey measures the public’s
knowledge, attitudes, and behaviors
relative to preparing for a wide range of
hazards.
DATES: Comments must be submitted on
or before April 23, 2021.
ADDRESSES: Written comments and
recommendations for the proposed
SUMMARY:
E:\FR\FM\24MRN1.SGM
24MRN1
]]>Agencies
[Federal Register Volume 86, Number 55 (Wednesday, March 24, 2021)]
[Notices]
[Page 15691]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-06020]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases;
Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Diabetes and Digestive and Kidney Diseases Advisory Council, May 12,
2021, 10:00 a.m. to May 13, 2021, 01:45 p.m., National Institutes of
Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD,
20892 which was published in the Federal Register on December 28, 2020,
85 FR 84358.
This notice is being amended to change the meeting time from 10:00
a.m.-1:15 p.m. on May 12, 2021 to 10:00 a.m.-3:00 p.m. on May 12, 2021.
The meeting is to the public.
Dated: March 18, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-06020 Filed 3-23-21; 8:45 am]
BILLING CODE 4140-01-P
